MedPath

MEDICAL GENETICS JOINT STOCK COMPANY

🇻🇳Vietnam
Ownership
-
Employees
-
Market Cap
-
Website

Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

Phase 1
Completed
Conditions
Colorectal Cancer
Liver Neoplasms
Interventions
First Posted Date
2005-09-08
Last Posted Date
2018-04-24
Lead Sponsor
MediGene
Target Recruit Count
32
Registration Number
NCT00149396
Locations
🇺🇸

Mary Crowley Medical Research Center, Dallas, Texas, United States

🇺🇸

University of California, San Diego, San Diego, California, United States

🇺🇸

University of Pittsburgh Cancer Center, Pittsburgh, Pennsylvania, United States

and more 2 locations

Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer

Phase 1
Completed
Conditions
Glioma
Astrocytoma
Glioblastoma
First Posted Date
2001-12-18
Last Posted Date
2005-06-24
Lead Sponsor
MediGene
Target Recruit Count
65
Registration Number
NCT00028158
© Copyright 2025. All Rights Reserved by MedPath